Refine Search
(16)
(36)
(50)
(94)

Immunology

GlobalData provides unique and market-leading data and insights into the immunology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Competitor Landscape: Sjögren's Syndrome

  • $6,400
  • December 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Sjögren's Syndrome market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) fo...

Competitor Landscape: Systemic Sclerosis (Scleroderma)

  • $6,400
  • December 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Systemic Sclerosis (Scleroderma) market, analysis of current & potential future product positioning, and forecast approval dates (by q...

Competitor Landscape: Graft Versus Host Disease (GVHD)

  • $6,400
  • December 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the graft versus host disease (GVHD) market, analysis of current & potential future product positioning, and forecast approval dates (by q...

Competitor Landscape: Rheumatoid Arthritis

  • $6,400
  • October 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Rheumatoid Arthritis (RA) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter)...

Competitor Landscape: Psoriasis

  • $6,400
  • October 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Psoriasis (PsO) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candi...

Competitor Landscape: Lupus

  • $6,400
  • October 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Lupus market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in P...

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Wiskott-Aldrich Syndrome clinical trials scenario. This report provides top line data relating to the clinic...

X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2018" provides an overview of X-Linked Agammaglobulinemia clinical trials scenario. This report provides top line data relating to the ...

Allergies Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Allergies Global Clinical Trials Review, H2, 2018" provides an overview of Allergies clinical trials scenario. This report provides top line data relating to the clinical trials on Allergies. Report...

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2018" provides an overview of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculit...

Angioedema Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Angioedema Global Clinical Trials Review, H2, 2018" provides an overview of Angioedema clinical trials scenario. This report provides top line data relating to the clinical trials on Angioedema. Rep...

KOL Perspectives: Perceptions of Lupus Pipeline Therapy Data Presented at EULAR 2018

  • $2,500
  • September 2018
Add to Basket Quick View Add to Saved List

This KOL Insight briefing focuses on KOLs views of Pipeline Therapy Data Presented at EULAR 2018

Digital Landscape: Ankylosing Spondylitis

  • $6,000
  • September 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Ankylosing Spondylitis report analyzes digital activities undertaken by pharma in support of therapies for active Ankylosing Spondylitis (AS)

Digital Landscape: Rheumatoid Arthritis

  • $6,000
  • September 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Rheumatoid Arthritis report analyzes digital activities undertaken by pharma in support of therapies for moderate-to-severe rheumatoid arthritis (RA).

Type I Hypersensitivity Global Clinical Trials Review, H2, 2018

  • $2,500
  • September 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Type I Hypersensitivity Global Clinical Trials Review, H2, 2018" provides an overview of Type I Hypersensitivity clinical trials scenario. This report provides top line data relating to the clinical...